- Home
- FTEL vs LAB Comparison
FTEL vs LAB Comparison
Compare FTEL & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- LAB
- Stock Information
- Founded
- FTEL 2007
- LAB 1999
- Country
- FTEL Australia
- LAB United States
- Employees
- FTEL N/A
- LAB N/A
- Industry
- FTEL
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- FTEL
- LAB Industrials
- Exchange
- FTEL Nasdaq
- LAB Nasdaq
- Market Cap
- FTEL 552.8M
- LAB 562.1M
- IPO Year
- FTEL 2023
- LAB 2011
- Fundamental
- Price
- FTEL $23.85
- LAB $1.62
- Analyst Decision
- FTEL
- LAB Strong Buy
- Analyst Count
- FTEL 0
- LAB 2
- Target Price
- FTEL N/A
- LAB $2.88
- AVG Volume (30 Days)
- FTEL 210.2K
- LAB 2.8M
- Earning Date
- FTEL 12-03-2024
- LAB 10-30-2024
- Dividend Yield
- FTEL N/A
- LAB N/A
- EPS Growth
- FTEL N/A
- LAB N/A
- EPS
- FTEL N/A
- LAB N/A
- Revenue
- FTEL $4,466,775.00
- LAB $155,902,000.00
- Revenue This Year
- FTEL N/A
- LAB $62.60
- Revenue Next Year
- FTEL N/A
- LAB $9.91
- P/E Ratio
- FTEL N/A
- LAB N/A
- Revenue Growth
- FTEL N/A
- LAB 48.23
- 52 Week Low
- FTEL $0.88
- LAB $1.21
- 52 Week High
- FTEL $39.89
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- FTEL 44.18
- LAB 39.48
- Support Level
- FTEL $27.00
- LAB $1.46
- Resistance Level
- FTEL $39.88
- LAB $1.69
- Average True Range (ATR)
- FTEL 5.51
- LAB 0.15
- MACD
- FTEL -0.91
- LAB -0.05
- Stochastic Oscillator
- FTEL 7.87
- LAB 18.60
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.